阿斯塔山丁对ANCA相关的血管炎的保护作用
Ruo-Lan Sun1, Jin-Chun Shang1, Run-Hong Han1
1Department of Renal Division, Affiliated Hospital of Qingdao University, Qingdao 266555, China.
International immunopharmacology
|March 27, 2024
概括
阿斯塔克桑丁 (ATX) 在治疗抗中性粒细胞体抗体 (ANCA) 相关血管炎 (AAV) 方面表现有前途. 这项研究发现,ATX减少了炎症和氧化应激,在AAV的实验模型中改善了器官损伤.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗中性细胞质抗体 (ANCA) 相关的血管炎 (AAV) 是一种由炎症和氧化应激驱动的系统性自身免疫性疾病.
- 阿斯塔桑丁 (ATX) 是一种胡卜素,具有已知的抗炎,抗氧化和免疫调节性质.
研究的目的:
- 调查ATX对AAV的潜在保护作用.
- 阐明在AAV中ATX作用的基本机制.
主要方法:
- 试验室内:中性粒细胞被ATX治疗,并使用来自髓氧化酶 (MPO) -ANCA阳性患者的血清进行刺激.
- 在体内:实验性自身免疫性血管炎 (EAV) 的老鼠模型用ATX.治疗.
- 评估了炎症标志物 (IL-6,TNF-α),氧化应激 (ROS,SOD,GSH-px),中性粒细胞外细胞陷 (NETs) 和器官损伤 (脏和肺部).
主要成果:
- ATX 抑制了中性粒细胞的IL-6和TNF-α分泌和降低活性氧物种 (ROS) 和NETs的释放.
- 在EAV大鼠中,ATX治疗减少了血液流血,蛋白尿和球膜损伤.
- 肺部出血和MPO沉积在脏和肺部显著减少,而抗氧化剂水平增加.
结论:
- ATX 显示出与 AAV 病变发生相关的显著抗炎和抗氧化作用.
- 在实验性AAV中,ATX改善了器官损伤,表明其作为AAV治疗剂的潜力.
更多相关视频
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.5K
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
7.2K
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...